Home
Dermaceutic

Cibler Yellow Cream Correcteur Anti-Taches, 15ml

Anti-dark spot corrective treatment in cream form. Targets and reduces the appearance of localized pigment spots through an exfoliating action.

Regulated compositionControversial ingredientPrecautions for sensitive groups
Safety

True or false, at a glance

Free from CMR-classified ingredients?
No

Contains: Acide salicylique

Free from endocrine disruptors?
No

Contains: Acide kojique, Acide salicylique

Free from fragrance allergens (Annex III)?
Yes
Fragrance-free?
No

Contains: Eau, Glycol de butylène, Palmitate de cétyle…

This corrective treatment in cream form is designed to target and reduce the appearance of localized pigment spots. Its formula contains glycolic and salicylic acids which promote cell renewal through an exfoliating action. This depigmenting concentrate is indicated for age-related spots, pigment rebound, melasma, and hormonal spots.

Ingredients

Composition

Every ingredient is clickable — discover its role and the products that contain it.

Safety

Precautions & sensitive groups

Pregnancy

Precaution · via RéglisseEn l’absence de données suffisantes, l’HMPC déconseille l’usage pendant la grossesse. À confirmer par le pharmacien.source: EMA/HMPC — Liquiritiae radix

Breastfeeding

Precaution · via RéglisseEn l’absence de données suffisantes, l’HMPC déconseille l’usage pendant l’allaitement. À confirmer par le pharmacien.source: EMA/HMPC — Liquiritiae radix

Child (< 12 years)

Precaution · via RéglisseL’HMPC ne recommande pas l’usage chez l’enfant de moins de 18 ans. À confirmer par le pharmacien.source: EMA/HMPC — Liquiritiae radix

Regulatory framework

What the authorities say

AuthorityStatus
Commission européenne (CosIng, Règl. 1223/2009) — via Acide kojiqueAutorisé sous conditions
ECHA — perturbateur endocrinien (santé humaine) — via Acide kojiquePerturbateur endocrinien — suspecté
Commission européenne (CosIng, Règl. 1223/2009) — via TriéthanolamineAutorisé sous conditions
Commission européenne (CosIng, Règl. 1223/2009) — via Alpha-ArbutineAutorisé sous conditions
Commission européenne (CosIng, Règl. 1223/2009) — via Acide salicyliqueAutorisé sous conditions
Classification CLP (Règl. 1272/2008) — via Acide salicyliqueReprotoxique — suspecté
ECHA — perturbateur endocrinien (santé humaine) — via Acide salicyliquePerturbateur endocrinien — suspecté
Commission européenne (CosIng, Règl. 1223/2009) — via Métabisulfite de sodiumAutorisé sous conditions
Commission européenne (CosIng, Règl. 1223/2009) — via Acide undécyléniqueAutorisé sous conditions
Commission européenne (CosIng, Règl. 1223/2009) — via Hydroxyde de sodiumAutorisé sous conditions
The brand

Dermaceutic

🔒
Independent explainer page, factual only (composition, authorities, reviews). This is not medical advice — for your situation, ask a pharmacist or a healthcare professional for advice.
Sources
EMA/HMPC — Liquiritiae radix
Trust

Transparency & method

Équipe Lou
Published on 7/17/2026Updated on 7/17/2026Sources verified on 7/17/2026
Scientific review: coming soon

How Lou builds its answers and chooses its sources →

Is this product right for you?

Lou analyses it with you based on your situation and preferences.

Analyse with Lou
Ask Lou a question